SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-033882
Filing Date
2024-08-01
Accepted
2024-08-01 07:27:45
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-20240630.htm   iXBRL 10-Q 1410180
2 EX-31.1 cccc-20240630xexx311.htm EX-31.1 10369
3 EX-31.2 cccc-20240630xexx312.htm EX-31.2 10415
4 EX-32.1 cccc-20240630xexx321.htm EX-32.1 4745
5 EX-32.2 cccc-20240630xexx322.htm EX-32.2 4756
  Complete submission text file 0001628280-24-033882.txt   5916841

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20240630.xsd EX-101.SCH 42137
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cccc-20240630_cal.xml EX-101.CAL 65667
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cccc-20240630_def.xml EX-101.DEF 182277
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20240630_lab.xml EX-101.LAB 434942
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20240630_pre.xml EX-101.PRE 296518
67 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20240630_htm.xml XML 755487
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 241164275
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)